2023 annual financial data
CytomX Therapeutics 2023 Net margin
Direct answer
Net margin was -0.56%.
Operating income was -6,484,000 USD and net income was -569,000 USD.
Operating cash flow was -56,035,000 USD.
Get free CytomX Therapeutics email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Revenue
- 101,214,000 USD
- Operating income
- -6,484,000 USD
- Net income
- -569,000 USD
- Operating cash flow
- -56,035,000 USD